anrukinzumab anrukinzumab anrukinzumab (ima-638) is a humanized monoclonal antibody designed for the treatment of asthma. anrukinzumabmonoclonal antibodytypewhole antibodysourcehumanized (from mouse)targetil13clinical dataatc codenoneidentifierscas number910649-32-0 nchemspidernoneuniiou46igc49fchemical and physical dataformulac6452h9954n1714o2024s46molar mass145393.34 g·mol−1 ny (what is this?) (verify) anrukinzumab was developed by wyeth.